Structure

Physi-Chem Properties

Molecular Weight:  518.36
Volume:  549.418
LogP:  3.214
LogD:  3.25
LogS:  -4.209
# Rotatable Bonds:  4
TPSA:  96.22
# H-Bond Aceptor:  6
# H-Bond Donor:  3
# Rings:  5
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.469
Synthetic Accessibility Score:  5.346
Fsp3:  0.903
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.879
MDCK Permeability:  1.0450610716361552e-05
Pgp-inhibitor:  0.979
Pgp-substrate:  0.003
Human Intestinal Absorption (HIA):  0.005
20% Bioavailability (F20%):  0.294
30% Bioavailability (F30%):  0.942

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.106
Plasma Protein Binding (PPB):  84.2606430053711%
Volume Distribution (VD):  1.53
Pgp-substrate:  8.716252326965332%

ADMET: Metabolism

CYP1A2-inhibitor:  0.003
CYP1A2-substrate:  0.32
CYP2C19-inhibitor:  0.01
CYP2C19-substrate:  0.842
CYP2C9-inhibitor:  0.053
CYP2C9-substrate:  0.125
CYP2D6-inhibitor:  0.004
CYP2D6-substrate:  0.096
CYP3A4-inhibitor:  0.322
CYP3A4-substrate:  0.326

ADMET: Excretion

Clearance (CL):  4.101
Half-life (T1/2):  0.75

ADMET: Toxicity

hERG Blockers:  0.016
Human Hepatotoxicity (H-HT):  0.299
Drug-inuced Liver Injury (DILI):  0.041
AMES Toxicity:  0.029
Rat Oral Acute Toxicity:  0.868
Maximum Recommended Daily Dose:  0.924
Skin Sensitization:  0.229
Carcinogencity:  0.017
Eye Corrosion:  0.004
Eye Irritation:  0.021
Respiratory Toxicity:  0.964

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC470065

Natural Product ID:  NPC470065
Common Name*:   3-O-Acetyl-21-O-Methyltoosendanpentol
IUPAC Name:   (5R,7R,8R,9R,10R,13S,17R)-17-[(2R,3S,5R)-5-[(1S)-1,2-dihydroxy-2-methylpropyl]-2-methoxyoxolan-3-yl]-7-hydroxy-4,4,8,10,13-pentamethyl-1,2,5,6,7,9,11,12,16,17-decahydrocyclopenta[a]phenanthren-3-one
Synonyms:  
Standard InCHIKey:  UTGJQBYMUPRIKQ-VMPVCBGCSA-N
Standard InCHI:  InChI=1S/C31H50O6/c1-27(2)22-16-24(33)31(7)20-10-9-18(17-15-19(37-26(17)36-8)25(34)28(3,4)35)29(20,5)13-11-21(31)30(22,6)14-12-23(27)32/h10,17-19,21-22,24-26,33-35H,9,11-16H2,1-8H3/t17-,18+,19+,21+,22-,24+,25-,26+,29-,30+,31-/m0/s1
SMILES:  CC1(C2CC(C3(C(C2(CCC1=O)C)CCC4(C3=CCC4C5CC(OC5OC)C(C(C)(C)O)O)C)C)O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1668618
PubChem CID:   53319631
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001553] Triterpenoids
          • [CHEMONTID:0002380] Limonoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO19151 Chisocheton paniculatus Species Meliaceae Eukaryota n.a. n.a. n.a. PMID[19943621]
NPO19151 Chisocheton paniculatus Species Meliaceae Eukaryota twigs Xishuangbanna, Yunnan, China 2007-May PMID[21288727]
NPO19151 Chisocheton paniculatus Species Meliaceae Eukaryota n.a. n.a. n.a. PMID[32208696]
NPO19151 Chisocheton paniculatus Species Meliaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT113 Cell Line RAW264.7 Mus musculus IC50 = 18200.0 nM PMID[484958]
NPT113 Cell Line RAW264.7 Mus musculus IC50 = 57500.0 nM PMID[484958]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC470065 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9167 High Similarity NPC302471
0.9048 High Similarity NPC469845
0.8942 High Similarity NPC470057
0.8942 High Similarity NPC470061
0.8942 High Similarity NPC470043
0.8942 High Similarity NPC470058
0.8942 High Similarity NPC470059
0.8942 High Similarity NPC470060
0.8942 High Similarity NPC470062
0.8942 High Similarity NPC470064
0.8942 High Similarity NPC100955
0.8942 High Similarity NPC121566
0.8919 High Similarity NPC161065
0.8899 High Similarity NPC477580
0.8879 High Similarity NPC101450
0.8857 High Similarity NPC95243
0.8857 High Similarity NPC63023
0.8839 High Similarity NPC241192
0.8807 High Similarity NPC471173
0.8807 High Similarity NPC471627
0.8727 High Similarity NPC472274
0.8704 High Similarity NPC52241
0.8704 High Similarity NPC475317
0.8704 High Similarity NPC154856
0.8679 High Similarity NPC210178
0.8679 High Similarity NPC472655
0.8667 High Similarity NPC471005
0.8547 High Similarity NPC298841
0.8545 High Similarity NPC210420
0.8545 High Similarity NPC474265
0.8545 High Similarity NPC130427
0.8532 High Similarity NPC5284
0.8519 High Similarity NPC258323
0.8505 High Similarity NPC470055
0.8505 High Similarity NPC470056
0.8482 Intermediate Similarity NPC243981
0.8468 Intermediate Similarity NPC293038
0.8468 Intermediate Similarity NPC178981
0.8468 Intermediate Similarity NPC255017
0.8468 Intermediate Similarity NPC62696
0.8462 Intermediate Similarity NPC5358
0.8462 Intermediate Similarity NPC216260
0.844 Intermediate Similarity NPC246205
0.844 Intermediate Similarity NPC118225
0.844 Intermediate Similarity NPC218853
0.8426 Intermediate Similarity NPC293512
0.8426 Intermediate Similarity NPC59530
0.8421 Intermediate Similarity NPC161738
0.8421 Intermediate Similarity NPC477071
0.8411 Intermediate Similarity NPC31430
0.8411 Intermediate Similarity NPC471293
0.8411 Intermediate Similarity NPC85593
0.8393 Intermediate Similarity NPC102088
0.8393 Intermediate Similarity NPC474557
0.8393 Intermediate Similarity NPC473882
0.8378 Intermediate Similarity NPC234042
0.8378 Intermediate Similarity NPC152117
0.8364 Intermediate Similarity NPC250956
0.8349 Intermediate Similarity NPC272576
0.8349 Intermediate Similarity NPC473288
0.8349 Intermediate Similarity NPC295389
0.8349 Intermediate Similarity NPC469844
0.8333 Intermediate Similarity NPC470587
0.8319 Intermediate Similarity NPC279638
0.8318 Intermediate Similarity NPC213190
0.8305 Intermediate Similarity NPC47113
0.8305 Intermediate Similarity NPC174367
0.8304 Intermediate Similarity NPC260665
0.8302 Intermediate Similarity NPC470054
0.8291 Intermediate Similarity NPC27363
0.8288 Intermediate Similarity NPC263827
0.8288 Intermediate Similarity NPC285410
0.8288 Intermediate Similarity NPC272242
0.8288 Intermediate Similarity NPC250481
0.8288 Intermediate Similarity NPC269466
0.8276 Intermediate Similarity NPC182900
0.8276 Intermediate Similarity NPC249553
0.8273 Intermediate Similarity NPC477070
0.8273 Intermediate Similarity NPC477069
0.8273 Intermediate Similarity NPC8431
0.8241 Intermediate Similarity NPC222161
0.8235 Intermediate Similarity NPC42399
0.8235 Intermediate Similarity NPC473166
0.823 Intermediate Similarity NPC165439
0.823 Intermediate Similarity NPC475633
0.823 Intermediate Similarity NPC74727
0.8224 Intermediate Similarity NPC470053
0.8224 Intermediate Similarity NPC136816
0.8214 Intermediate Similarity NPC46388
0.8214 Intermediate Similarity NPC471245
0.8214 Intermediate Similarity NPC37739
0.8214 Intermediate Similarity NPC174836
0.8208 Intermediate Similarity NPC324598
0.8205 Intermediate Similarity NPC28532
0.8205 Intermediate Similarity NPC169816
0.8205 Intermediate Similarity NPC15918
0.8205 Intermediate Similarity NPC305771
0.8205 Intermediate Similarity NPC94072
0.8198 Intermediate Similarity NPC274507
0.8198 Intermediate Similarity NPC129340
0.819 Intermediate Similarity NPC472257
0.819 Intermediate Similarity NPC471406
0.8182 Intermediate Similarity NPC94942
0.8182 Intermediate Similarity NPC230888
0.8174 Intermediate Similarity NPC239293
0.8173 Intermediate Similarity NPC180557
0.8173 Intermediate Similarity NPC37787
0.8173 Intermediate Similarity NPC473415
0.8173 Intermediate Similarity NPC30677
0.8173 Intermediate Similarity NPC469329
0.8167 Intermediate Similarity NPC311534
0.8165 Intermediate Similarity NPC473199
0.8158 Intermediate Similarity NPC134869
0.8158 Intermediate Similarity NPC152199
0.8158 Intermediate Similarity NPC235539
0.8155 Intermediate Similarity NPC198074
0.8155 Intermediate Similarity NPC274046
0.8151 Intermediate Similarity NPC469750
0.8151 Intermediate Similarity NPC250556
0.8142 Intermediate Similarity NPC269315
0.8142 Intermediate Similarity NPC189884
0.8142 Intermediate Similarity NPC204458
0.8142 Intermediate Similarity NPC251309
0.8142 Intermediate Similarity NPC47063
0.8142 Intermediate Similarity NPC271138
0.8142 Intermediate Similarity NPC102619
0.8142 Intermediate Similarity NPC477944
0.8142 Intermediate Similarity NPC311592
0.8142 Intermediate Similarity NPC75167
0.8142 Intermediate Similarity NPC138334
0.8131 Intermediate Similarity NPC309425
0.8131 Intermediate Similarity NPC47566
0.8131 Intermediate Similarity NPC129372
0.8131 Intermediate Similarity NPC88000
0.8131 Intermediate Similarity NPC4831
0.8131 Intermediate Similarity NPC472023
0.8131 Intermediate Similarity NPC160734
0.8125 Intermediate Similarity NPC477073
0.8125 Intermediate Similarity NPC471243
0.8125 Intermediate Similarity NPC108748
0.8125 Intermediate Similarity NPC190837
0.8125 Intermediate Similarity NPC297208
0.8125 Intermediate Similarity NPC122339
0.8125 Intermediate Similarity NPC201992
0.8125 Intermediate Similarity NPC30397
0.8125 Intermediate Similarity NPC235841
0.8125 Intermediate Similarity NPC274833
0.8125 Intermediate Similarity NPC211798
0.8125 Intermediate Similarity NPC191763
0.8125 Intermediate Similarity NPC473481
0.812 Intermediate Similarity NPC476672
0.812 Intermediate Similarity NPC202051
0.812 Intermediate Similarity NPC204731
0.8113 Intermediate Similarity NPC470068
0.8113 Intermediate Similarity NPC470066
0.8113 Intermediate Similarity NPC470067
0.8113 Intermediate Similarity NPC234287
0.8113 Intermediate Similarity NPC280825
0.8108 Intermediate Similarity NPC41405
0.8108 Intermediate Similarity NPC204407
0.8108 Intermediate Similarity NPC265655
0.8108 Intermediate Similarity NPC57362
0.8108 Intermediate Similarity NPC143706
0.8108 Intermediate Similarity NPC167383
0.8108 Intermediate Similarity NPC306746
0.8108 Intermediate Similarity NPC237503
0.8108 Intermediate Similarity NPC137917
0.8108 Intermediate Similarity NPC472534
0.8103 Intermediate Similarity NPC122971
0.8103 Intermediate Similarity NPC178548
0.8103 Intermediate Similarity NPC258592
0.8091 Intermediate Similarity NPC283849
0.8091 Intermediate Similarity NPC473165
0.8087 Intermediate Similarity NPC13713
0.8087 Intermediate Similarity NPC477252
0.8087 Intermediate Similarity NPC309433
0.8083 Intermediate Similarity NPC305496
0.8083 Intermediate Similarity NPC471357
0.8083 Intermediate Similarity NPC117702
0.8083 Intermediate Similarity NPC329784
0.8083 Intermediate Similarity NPC240070
0.8083 Intermediate Similarity NPC179412
0.8083 Intermediate Similarity NPC146456
0.8083 Intermediate Similarity NPC469757
0.8083 Intermediate Similarity NPC471356
0.8077 Intermediate Similarity NPC240617
0.807 Intermediate Similarity NPC475163
0.807 Intermediate Similarity NPC116024
0.807 Intermediate Similarity NPC181145
0.807 Intermediate Similarity NPC474906
0.807 Intermediate Similarity NPC326542
0.807 Intermediate Similarity NPC18547
0.8067 Intermediate Similarity NPC473505
0.8067 Intermediate Similarity NPC475194
0.8067 Intermediate Similarity NPC476674
0.8053 Intermediate Similarity NPC161434
0.8053 Intermediate Similarity NPC473303
0.8053 Intermediate Similarity NPC212968
0.8053 Intermediate Similarity NPC64106
0.8053 Intermediate Similarity NPC195132

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC470065 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8362 Intermediate Similarity NPD6370 Approved
0.819 Intermediate Similarity NPD6059 Approved
0.819 Intermediate Similarity NPD6054 Approved
0.8167 Intermediate Similarity NPD7736 Approved
0.8151 Intermediate Similarity NPD7507 Approved
0.8091 Intermediate Similarity NPD6412 Phase 2
0.8083 Intermediate Similarity NPD8293 Discontinued
0.7966 Intermediate Similarity NPD6016 Approved
0.7966 Intermediate Similarity NPD6015 Approved
0.7951 Intermediate Similarity NPD7319 Approved
0.7917 Intermediate Similarity NPD7492 Approved
0.7899 Intermediate Similarity NPD5988 Approved
0.7851 Intermediate Similarity NPD6616 Approved
0.7788 Intermediate Similarity NPD8132 Clinical (unspecified phase)
0.7787 Intermediate Similarity NPD7078 Approved
0.7778 Intermediate Similarity NPD8295 Clinical (unspecified phase)
0.7748 Intermediate Similarity NPD8170 Clinical (unspecified phase)
0.7686 Intermediate Similarity NPD8328 Phase 3
0.7627 Intermediate Similarity NPD6009 Approved
0.7586 Intermediate Similarity NPD6882 Approved
0.7581 Intermediate Similarity NPD6033 Approved
0.7563 Intermediate Similarity NPD7328 Approved
0.7563 Intermediate Similarity NPD7327 Approved
0.7544 Intermediate Similarity NPD6686 Approved
0.7544 Intermediate Similarity NPD7320 Approved
0.7541 Intermediate Similarity NPD6067 Discontinued
0.7522 Intermediate Similarity NPD7128 Approved
0.7522 Intermediate Similarity NPD6402 Approved
0.7522 Intermediate Similarity NPD5739 Approved
0.7522 Intermediate Similarity NPD6008 Approved
0.7522 Intermediate Similarity NPD6675 Approved
0.7521 Intermediate Similarity NPD4632 Approved
0.7521 Intermediate Similarity NPD8033 Approved
0.7521 Intermediate Similarity NPD8133 Approved
0.75 Intermediate Similarity NPD7516 Approved
0.7438 Intermediate Similarity NPD6319 Approved
0.7438 Intermediate Similarity NPD8377 Approved
0.7438 Intermediate Similarity NPD8294 Approved
0.7436 Intermediate Similarity NPD8297 Approved
0.7391 Intermediate Similarity NPD6899 Approved
0.7391 Intermediate Similarity NPD6881 Approved
0.7377 Intermediate Similarity NPD8378 Approved
0.7377 Intermediate Similarity NPD8380 Approved
0.7377 Intermediate Similarity NPD8335 Approved
0.7377 Intermediate Similarity NPD8379 Approved
0.7377 Intermediate Similarity NPD8296 Approved
0.7364 Intermediate Similarity NPD4755 Approved
0.7358 Intermediate Similarity NPD5328 Approved
0.7328 Intermediate Similarity NPD6372 Approved
0.7328 Intermediate Similarity NPD6373 Approved
0.7315 Intermediate Similarity NPD6399 Phase 3
0.7304 Intermediate Similarity NPD5701 Approved
0.7304 Intermediate Similarity NPD5697 Approved
0.7265 Intermediate Similarity NPD6883 Approved
0.7265 Intermediate Similarity NPD7290 Approved
0.7265 Intermediate Similarity NPD7102 Approved
0.7265 Intermediate Similarity NPD4634 Approved
0.7241 Intermediate Similarity NPD5345 Clinical (unspecified phase)
0.7232 Intermediate Similarity NPD4696 Approved
0.7232 Intermediate Similarity NPD5285 Approved
0.7232 Intermediate Similarity NPD5286 Approved
0.7232 Intermediate Similarity NPD4700 Approved
0.7222 Intermediate Similarity NPD6079 Approved
0.7212 Intermediate Similarity NPD4786 Approved
0.7203 Intermediate Similarity NPD8130 Phase 1
0.7203 Intermediate Similarity NPD6649 Approved
0.7203 Intermediate Similarity NPD6847 Approved
0.7203 Intermediate Similarity NPD6617 Approved
0.7203 Intermediate Similarity NPD6869 Approved
0.7203 Intermediate Similarity NPD6650 Approved
0.7179 Intermediate Similarity NPD6014 Approved
0.7179 Intermediate Similarity NPD6012 Approved
0.7179 Intermediate Similarity NPD6013 Approved
0.7143 Intermediate Similarity NPD7638 Approved
0.712 Intermediate Similarity NPD7604 Phase 2
0.7105 Intermediate Similarity NPD5224 Approved
0.7105 Intermediate Similarity NPD5211 Phase 2
0.7105 Intermediate Similarity NPD5225 Approved
0.7105 Intermediate Similarity NPD5226 Approved
0.7105 Intermediate Similarity NPD4633 Approved
0.7097 Intermediate Similarity NPD8515 Approved
0.7097 Intermediate Similarity NPD8513 Phase 3
0.7097 Intermediate Similarity NPD8516 Approved
0.7097 Intermediate Similarity NPD5983 Phase 2
0.7097 Intermediate Similarity NPD8517 Approved
0.7094 Intermediate Similarity NPD6011 Approved
0.708 Intermediate Similarity NPD7639 Approved
0.708 Intermediate Similarity NPD7640 Approved
0.7059 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.7049 Intermediate Similarity NPD7115 Discovery
0.7043 Intermediate Similarity NPD5175 Approved
0.7043 Intermediate Similarity NPD5174 Approved
0.7034 Intermediate Similarity NPD4061 Clinical (unspecified phase)
0.7019 Intermediate Similarity NPD3667 Approved
0.7018 Intermediate Similarity NPD5223 Approved
0.7008 Intermediate Similarity NPD6336 Discontinued
0.7 Intermediate Similarity NPD4202 Approved
0.699 Remote Similarity NPD7525 Registered
0.6983 Remote Similarity NPD5141 Approved
0.6964 Remote Similarity NPD5220 Clinical (unspecified phase)
0.6964 Remote Similarity NPD5221 Approved
0.6964 Remote Similarity NPD4697 Phase 3
0.6964 Remote Similarity NPD5222 Approved
0.696 Remote Similarity NPD7503 Approved
0.6937 Remote Similarity NPD7748 Approved
0.6923 Remote Similarity NPD4768 Approved
0.6923 Remote Similarity NPD4767 Approved
0.6916 Remote Similarity NPD3618 Phase 1
0.6909 Remote Similarity NPD7515 Phase 2
0.6909 Remote Similarity NPD8035 Phase 2
0.6909 Remote Similarity NPD8034 Phase 2
0.6903 Remote Similarity NPD7902 Approved
0.6903 Remote Similarity NPD5173 Approved
0.6903 Remote Similarity NPD6083 Phase 2
0.6903 Remote Similarity NPD6084 Phase 2
0.6897 Remote Similarity NPD4754 Approved
0.6847 Remote Similarity NPD8171 Discontinued
0.6829 Remote Similarity NPD6274 Approved
0.6822 Remote Similarity NPD7520 Clinical (unspecified phase)
0.6807 Remote Similarity NPD4729 Approved
0.6807 Remote Similarity NPD4730 Approved
0.6807 Remote Similarity NPD5128 Approved
0.68 Remote Similarity NPD7101 Approved
0.68 Remote Similarity NPD7100 Approved
0.6794 Remote Similarity NPD5956 Approved
0.6727 Remote Similarity NPD4753 Phase 2
0.6726 Remote Similarity NPD6356 Clinical (unspecified phase)
0.6721 Remote Similarity NPD6053 Discontinued
0.672 Remote Similarity NPD6335 Approved
0.6697 Remote Similarity NPD7524 Approved
0.6696 Remote Similarity NPD4225 Approved
0.6694 Remote Similarity NPD5251 Approved
0.6694 Remote Similarity NPD5248 Approved
0.6694 Remote Similarity NPD5249 Phase 3
0.6694 Remote Similarity NPD5955 Clinical (unspecified phase)
0.6694 Remote Similarity NPD5247 Approved
0.6694 Remote Similarity NPD5250 Approved
0.6693 Remote Similarity NPD6909 Approved
0.6693 Remote Similarity NPD6908 Approved
0.6693 Remote Similarity NPD6291 Clinical (unspecified phase)
0.6667 Remote Similarity NPD7632 Discontinued
0.6667 Remote Similarity NPD3703 Phase 2
0.664 Remote Similarity NPD6317 Approved
0.6639 Remote Similarity NPD5216 Approved
0.6639 Remote Similarity NPD5217 Approved
0.6639 Remote Similarity NPD5215 Approved
0.6637 Remote Similarity NPD7900 Approved
0.6637 Remote Similarity NPD5282 Discontinued
0.6637 Remote Similarity NPD7901 Clinical (unspecified phase)
0.6635 Remote Similarity NPD6114 Approved
0.6635 Remote Similarity NPD6115 Approved
0.6635 Remote Similarity NPD6697 Approved
0.6635 Remote Similarity NPD6118 Approved
0.6607 Remote Similarity NPD6411 Approved
0.6587 Remote Similarity NPD6314 Approved
0.6587 Remote Similarity NPD6313 Approved
0.6579 Remote Similarity NPD5695 Phase 3
0.6574 Remote Similarity NPD7338 Clinical (unspecified phase)
0.6574 Remote Similarity NPD3666 Approved
0.6574 Remote Similarity NPD3133 Approved
0.6574 Remote Similarity NPD3668 Phase 3
0.6574 Remote Similarity NPD3665 Phase 1
0.6565 Remote Similarity NPD8074 Phase 3
0.6562 Remote Similarity NPD6921 Approved
0.656 Remote Similarity NPD6868 Approved
0.6557 Remote Similarity NPD5134 Clinical (unspecified phase)
0.6557 Remote Similarity NPD5135 Approved
0.6557 Remote Similarity NPD5169 Approved
0.6552 Remote Similarity NPD5696 Approved
0.6538 Remote Similarity NPD6116 Phase 1
0.6509 Remote Similarity NPD6928 Phase 2
0.6504 Remote Similarity NPD5127 Approved
0.6504 Remote Similarity NPD8413 Clinical (unspecified phase)
0.6486 Remote Similarity NPD6672 Approved
0.6486 Remote Similarity NPD6903 Approved
0.6486 Remote Similarity NPD7513 Clinical (unspecified phase)
0.6486 Remote Similarity NPD5737 Approved
0.6481 Remote Similarity NPD4788 Approved
0.6481 Remote Similarity NPD6695 Phase 3
0.6455 Remote Similarity NPD6684 Approved
0.6455 Remote Similarity NPD7521 Approved
0.6455 Remote Similarity NPD5330 Approved
0.6455 Remote Similarity NPD7146 Approved
0.6455 Remote Similarity NPD7334 Approved
0.6455 Remote Similarity NPD3574 Clinical (unspecified phase)
0.6455 Remote Similarity NPD6409 Approved
0.6446 Remote Similarity NPD5954 Clinical (unspecified phase)
0.6442 Remote Similarity NPD6117 Approved
0.6435 Remote Similarity NPD5210 Approved
0.6435 Remote Similarity NPD4629 Approved
0.6429 Remote Similarity NPD5764 Clinical (unspecified phase)
0.6429 Remote Similarity NPD6101 Approved
0.6429 Remote Similarity NPD6940 Discontinued
0.6423 Remote Similarity NPD6371 Approved
0.6415 Remote Similarity NPD7645 Phase 2
0.6404 Remote Similarity NPD5778 Approved
0.6404 Remote Similarity NPD5779 Approved
0.6396 Remote Similarity NPD3573 Approved
0.6393 Remote Similarity NPD5168 Approved
0.6389 Remote Similarity NPD4221 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data